Pt Prodia Widyahusada Tbk · IDX:PRDA
Pt Prodia Widyahusada Tbk — Q1 2020 Earnings Presentation
28 slides from Pt Prodia Widyahusada Tbk's earnings presentation, June 2020
Slide 1: 1Q 2020 Results Update
1Q 2020 Results Update June 2020 prodia.co.id This presentation has been prepared specifically by Prodia. The content of this presentation may not be used, duplicated or transmitted in any form without the written consent from Prodia. All rights reserved.
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by PT Prodia Widyahusada (the "Company") solely for use in connection with the analyst presentation relating to the Company. The information contained in this presentation is strictly confidential and is provided to you solely for your reference. By vie
Slide 3: List of Figures
List of Figures Market & Business Highlights 04 Business & Financial Updates 21 Indonesia’s Economy Outlook 05 Revenue 22 (COVID-19 Impact) Post COVID-19 Points of Impact 06 Quarterly Revenue 23 Digital Transformation on Healthcare 07 E-Prodia 24 Market Share 09 Gross Profit & Net Income 25 Services
Slide 4: Market & Business Highlights
Market & Business Highlights 4
Slide 5: Economy Outlook 2020
Economy Outlook 2020 The Impact of Coronavirus Outbreak Indonesia Economy Outlook 2020-2021 Post COVID-19 Outbreak Indonesia’s World Year OECD* ADB** IMF*** Govt’ Bank (Jun 20) (Apr 20) (Apr 20) (Jun 20) (Jun 20) 2020 -0.4% to 2.3% 0.0% -3.9% to -2.8% 2.5% 0.5% 2021 4.5 to 5.5% 4.8% 2.6% to 5.2% 5.0
Slide 6: Post COVID-19 Points of Impact for Healthcare System & Life Science Industry
Post Launch COVID-19 Points of Impact for Healthcare System & Life Science Industry The Southeast Asia Macro Trends Future Healthcare Engagement with System and Medicine Demand Healthcare Pharmaceutical & Supply Professionals Industry Environment Fluctuating demand Decline of healthcare Fallin
Slide 7: Digital Transformation in Indonesia's Healthcare Services
Digital Transformation in Indonesia’s Healthcare Services Accelerated on Technology Adoption for Healthcare Indonesia is the largest and There are 318,000 health fastest growing internet apps available globally on economy in Southeast Asia. Google Play and Apple app Expecting compound annual stores,
Slide 8: Shifting to Digital Services
Shifting to Digital Services Indonesian Consumer Survey – Post Covid Condition Have you used ore done any of the following since COVID-19 started? User Growth and Intent to Use after COVID-19 User Intent to Activities Growth Continue Online fitness 29% 67% Wellness app 35% 69% Telemedicine: physical
Slide 9: Largest Network & Market Share in Independent Clinical Lab Industry
Largest Network & Market Share in Independent Clinical Lab Industry Market Share by Revenue Independent Clinical Labs (2017 & 2018) 38.7% 38.8% 29.0% 2017 28.2% 2018 32.3% 33.0% Source: IQVIA Analysis (2019) Note: Next 5 Players consists of: 1) Kimia Farma, 2) Pramita, 3) Parahita, 4) BioMedika , 5)
Slide 10: Comprehensive Service Offering
Comprehensive Service Offering Targets Multiple Customer Segments Routine Testing Non-Laboratory Testing Specialty Clinics Esoteric Testing Referral Lab Services Doctor Consultation Predictive, Preventive, General Medical Preventive Treatment Personalized Package Check-Up Services Testing Walk-In Cu
Slide 11: Prodia Laboratories
Prodia Laboratories Indonesian Pioneer in Clinical Laboratory Testing Received SMK3 accreditation and OHSAS 2015, along Established with the Award as "Diagnostic Services Company of the professional Year 2015" from Frost & Sullivan 2019 management team Opened the first green building used for
Slide 12: Scalable Hub and Spoke Model
Scalable Hub and Spoke Model Significant Economies of Scale Achieved Prodia Clinical Labs, Centralized information Hospitals and Other Prodia Referral with integrated IT “Hub and spoke” model Clinics may refer tests to Lab Services platform that connects offers scalable platform PRLS (PRLS) each lab
Slide 13: 2019-2020 Awards
2019-2020 Awards WOW Brand Award From Markplus Inc. Service Quality Award From Carre Service Quality Monitoring Corporate Image Award From Frontier Consulting Group & Marketing Magazine Top Brand Award From Frontier Consulting Group & Marketing Magazine Social Media Award From Marketing Ma
Slide 14: Senior Leadership and Management Team
Senior Leadership and Management Team Experienced, Professional Management Team with a Track Record in Delivering Superior Growth and Innovation Years of Years of Years of Years of Years of 47 Experience 47 Experience 37 Experience 31 Experience 33 Experience Andi Gunawan Endang Scott Andrew Lukas S
Slide 15: Shareholder Composition
Shareholder Composition PT Prodia Utama Bio Majesty Pte. Ltd. Public 57% 18% 25% Contract Research, therapy Distributor for Research and banking of healthcare Organization stem cell products PT Prodia Widyahusada Tbk Occupational In Vitro Health Diagnostics Nationwide Outlet Network across Indonesia
Slide 16: Growth Strategy
ail Growth Strategy
Slide 17: Growth Strategy
Growth Strategy A Near-term B Long-term Expand our presence and grow Focus on the development of next- our network of outlets in both generation diagnostic existing and new markets in technologies for precision medicine Indonesia Upgrade existing clinical laboratories to provide wider range of tests
Slide 18: Near Term Growth Plan
Near Term Growth Plan Prodia’s Network Expansion Plan 2016 - 2021 1 2 3 4 Expand Network Upgrade Clinical Enhance Operating Focus on of Outlets Labs Efficiency Quality 31 regional referral labs Upgrade up to 39 clinical labs to PHC3 Clinics Up to 33 additional clinical labs over next five years 24 C
Slide 19: FY2016-2019 Total Outlets & Development Targets
Business Updates FY2016-2019 Total Outlets & Development Targets 129 118 9 2 FY2016 259 Outlets Clinical Labs POC Outlets Hospital Labs Specialty Clinic 136 130 11 5 FY2017 283 Outlets Clinical Labs POC Outlets Hospital Labs Specialty Clinic 143 128 14 7 FY2018 292 Outlets Clinical Labs POC Outlets
Slide 20: Leader in Next Generation Technology
Leader in Next Generation Technology Research Evaluation Laboratory Laboratory Mass Spectrometry & Molecular Separation Next Generation Diagnostic Science Laboratory Laboratory Laboratory Anatomical Advance Pathology Immunology Laboratory Laboratory Personalized Treatment The Concept of Precision Me
Slide 21: 1Q2020 Business & Financial Updates
1Q2020 Business & Financial Updates 21
Slide 22: 1Q2020 Revenue (Unaudited)
Business Updates 1Q2020 Revenue (Unaudited) Revenue (in IDR Billion) FY16-FY19 CAGR +8.7% 1Q2016-1Q2020 CAGR+5.9% 1,744.3 1,599.8 1,466.0 Visit and volume were 1,359.0 slowing down on g+12.1% g-2.0% March 2020 due to COVID-19 outbreak and lockdown policy 399.5 391.4 in Indonesia 311.4 331.6 356.4 20
Slide 23: Quarterly Revenue Trends (Unaudited)
Business Updates Quarterly Revenue Trends (Unaudited) Quarterly Revenue 2016 – 2020 (in IDR Billion) 550 500 450 2020 Quarterly revenue 1Q2020, illustrates seasonality 391.4 2019 in the business that is 400 2018 affected by different variables each quarter, 350 2017 including Public 2016 Holiday & C
Slide 24: Technology to increase Customer Satisfaction
Business Updates Technology to increase Customer Satisfaction Online Order via Prodia Mobile Online Results via Prodia Mobile 24
Slide 25: 1Q2020 Gross Profit & Net Income (Unaudited)
Financial Updates 1Q2020 Gross Profit & Net Income (Unaudited) Gross Profit (in IDR Billion) Net Income (in IDR Billion) 1Q2017–1Q2020 CAGR +5.3% 1Q2017–1Q2020 CAGR +2.5% Growth -5.1% Growth -27.4% 236.0 223.9 203.2 47.9 191.9 32.3 32.5 34.8 57.9% 59.1% 12.0% 57.0% 57.2% 9.7% 9.1% 8.9% 1Q2017 1Q2018
Slide 26: 1Q2020 COGS & OPEX (Unaudited)
Financial Updates 1Q2020 COGS & OPEX (Unaudited) COGS (in IDR Billion) OPEX (in IDR Billion) 1Q2017–1Q2020 1Q2017–1Q2020 CAGR 2016-2019 +7.6% CAGR 2016-2019 +8.3% CAGR +6.3% CAGR +6.1% 703 50.0% 657 1,000 g +3.1% 6 612 g+2.5% 827 565 770 126 713 114 800 676 50 5 101 45.0% 46 90 43.0% 42.8% 39 41 41.
Slide 27: Financial Summary 1Q2020 (Unaudited)
Financial Updates Financial Summary 1Q2020 (Unaudited) (in IDR Bn) 1Q2020 1Q2019 Revenue 391.38 399.47 Gross Profit 223.88 236.00 EBIT 29.10 47.77 EBT 41.12 59.05 Net Income 34.70 47.96 EPS 37.10 51.16 EBITDA 72.00 76.84 27
Slide 28: Thank You
Thank You For more information : PT Prodia Widyahusada Tbk Investor.Relation@prodia.co.id Prodia Tower, Jl. Kramat Raya No. 150, Jakarta 10430, Indonesia Phone +6221.3144182 ext. 3774, 3775 http://www.prodia.co.id 1500-830 e-prodia @prodia_lab Laboratorium Klinik Prodia prodia.co.id
PT Prodia Widyahusada — Q1 2020 Earnings Presentation on 6ix